Literature DB >> 2847482

A new human pleomorphic hepatocellular carcinoma cell line, KYN-2.

H Yano1, M Maruiwa, T Murakami, K Fukuda, Y Ito, S Sugihara, M Kojiro.   

Abstract

A new human hepatocellular carcinoma (HCC) cell line, KYN-2, has been established from a surgical specimen obtained from a 52-year-old Japanese male HCC patient. The originally resected HCC was classified as pleomorphic HCC corresponding to Edmondson-Steiner's grade III with a thick trabecular to solid arrangement. The cell line has been maintained for 17 months through 35 passages. Morphologically, the KYN-2 cells have retained the characteristics of the original HCC, being pleomorphic and composed of various types such as cells with relatively small, polygonal, eosinophilic cytoplasm and oval-shaped nuclei with a marked tendency to pile up, flat cells with abundant clear cytoplasm and oval-shaped nuclei, and many multinucleated giant cells, proliferating in a pavement-like cell arrangement. Some junctional complexes and a number of microvilli are evident between the cells by electron microscopy. Functionally, these cells were found to secrete albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin, ceruloplasmin, transferrin, complement C, fibrinogen, fibronectin, prothrombin, retinol-binding protein (serum type), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), ferritin and beta 2-microglobulin in chemically defined medium (CDM). The secretion of AFP and CEA is apparently dependent upon culture medium and passage. The doubling time of cells growing in serum-containing medium at the 14th passage was 84 h, and those of cells in serum-containing medium, HB101 (serum-free medium) and CDM at late passage were 28, 68, and 42 h, respectively. Chromosome analysis revealed that the chromosome number ranged from 56 to 69 without a mode, and the presence of marker chromosomes. HB virus DNA sequence was not detected by hybridization analysis. The tumorigenicity of KYN-2 cells was identified by development of tumors in nude mice after subcutaneous injection of the cells; the tumors showed an appearance basically similar to that of the original HCC. Thus, these findings suggest that the KYN-2 cell line is available as a new human HCC cell line and should be useful for various studies on HCC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847482     DOI: 10.1111/j.1440-1827.1988.tb02368.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  14 in total

1.  Antiproliferative effect of ME3738, a derivative of soyasapogenol, on hepatocellular carcinoma cell lines in vitro and in vivo.

Authors:  Sachiko Ogasawara; Jun Akiba; Masamichi Nakayama; Hironori Kusano; Hirohisa Yano
Journal:  Biomed Rep       Date:  2016-10-25

Review 2.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

3.  Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98.

Authors:  Chao-Yang Lou; Ying-Ming Feng; Ai-Rong Qian; Yu Li; Hao Tang; Peng Shang; Zhi-Nan Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

Review 4.  Human cell lines in pharmacotoxicology. An introduction to a panel discussion.

Authors:  A M Batt; L Ferrari; A Abid; N Sabolović
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

5.  Inducibility of ethoxyresorufin deethylase and UDP-glucuronosyltransferase activities in two human hepatocarcinoma cell lines KYN-2 and Mz-Hep-1.

Authors:  A Abid; N Sabolovic; J Magdalou
Journal:  Cell Biol Toxicol       Date:  1996-04       Impact factor: 6.691

6.  Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma.

Authors:  M A Rumi; H Sato; S Ishihara; K Kawashima; S Hamamoto; H Kazumori; T Okuyama; R Fukuda; N Nagasue; Y Kinoshita
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

7.  Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.

Authors:  Takuji Torimura; Hideki Iwamoto; Toru Nakamura; Mitsuhiko Abe; Yu Ikezono; Fumitaka Wada; Takahiko Sakaue; Hiroshi Masuda; Osamu Hashimoto; Hironori Koga; Takato Ueno; Hirohisa Yano
Journal:  Neoplasia       Date:  2016-07       Impact factor: 5.715

8.  Phosphorylation of mTOR Ser2481 is a key target limiting the efficacy of rapalogs for treating hepatocellular carcinoma.

Authors:  Kosuke Watari; Ayumi Nishitani; Tomohiro Shibata; Masaki Noda; Akihiko Kawahara; Jun Akiba; Yuichi Murakami; Hirohisa Yano; Michihiko Kuwano; Mayumi Ono
Journal:  Oncotarget       Date:  2016-07-26

9.  Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line.

Authors:  Sachiko Ogasawara; Masamichi Nakayama; Jun Akiba; Hironori Kusano; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

10.  Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.

Authors:  Hironori Kusano; Jun Akiba; Sachiko Ogasawara; Sakiko Sanada; Makiko Yasumoto; Masamichi Nakayama; Keiko Ueda; Kosuke Ueda; Takashi Kurita; Keita Todoroki; Yumi Umeno; Osamu Nakashima; Hirohisa Yano
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.